Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Actinic Keratosis (AK)”

57 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 57 results

Not applicableLooking for participantsNCT07335003
What this trial is testing

Study of the Photoprotection and Prevention of Actinic Damage With Anthelios Fluide 100 KA+ UVMune 400 in Patients With Multiple Actinic Keratoses

Who this might be right for
Actinic Keratosis (AK)
Cosmetique Active International 80
Large-scale testing (Phase 3)Study completedNCT03285477
What this trial is testing

A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or Scalp

Who this might be right for
Actinic Keratoses
Almirall, S.A. 351
Large-scale testing (Phase 3)Study completedNCT02799082
What this trial is testing

Evaluation of Efficacy and Safety of BF-200 ALA Used With Photodynamic Therapy in Patients With Actinic Keratosis.

Who this might be right for
Actinic Keratosis
Biofrontera Bioscience GmbH 122
Large-scale testing (Phase 3)Study completedNCT00308867
What this trial is testing

PD P 506 A-PDT Versus Placebo-PDT and Cryosurgery for the Treatment of AK

Who this might be right for
Actinic Keratosis
photonamic GmbH & Co. KG 349
Not applicableStudy completedNCT05522036
What this trial is testing

Clinical Evaluation of a Short Illumination Duration (35 Minutes) When Performing PDT of AK Using the Dermaris ®

Who this might be right for
Actinic Keratoses
Centre Dermatologique du Roy 25
Testing effectiveness (Phase 2)UnknownNCT00829192
What this trial is testing

Phase II AK Study in Organ Transplant Patients

Who this might be right for
Actinic KeratosesCarcinoma, Squamous CellOrgan Transplant Recipients
Clinuvel Pharmaceuticals Limited 200
Not applicableWithdrawnNCT00814528
What this trial is testing

Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses

Who this might be right for
Actinic Keratosis
University of Chicago
Testing effectiveness (Phase 2)Study completedNCT01475955
What this trial is testing

Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK)

Who this might be right for
Actinic Keratosis
DUSA Pharmaceuticals, Inc. 235
Large-scale testing (Phase 3)WithdrawnNCT03024060
What this trial is testing

Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp

Who this might be right for
Actinic Keratosis
DUSA Pharmaceuticals, Inc.
Post-approval studies (Phase 4)Study completedNCT03511326
What this trial is testing

PRO With Luxerm® in the Field Treatment of Thin and Non-hyperkeratotic Non-pigmented AK

Who this might be right for
Actinic Keratoses
Galderma R&D 50
Not applicableStudy completedNCT00989313
What this trial is testing

A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study

Who this might be right for
Actinic Keratosis
Peplin 43
Testing effectiveness (Phase 2)Study completedNCT00107965
What this trial is testing

Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Actinic Keratoses

Who this might be right for
Actinic Keratosis
Peplin 60
Large-scale testing (Phase 3)Study completedNCT02124733
What this trial is testing

Protocols for Painless Photodynamic Therapy (PDT) of Actinic Keratoses

Who this might be right for
Actinic Keratosis
The Cleveland Clinic 23
Testing effectiveness (Phase 2)Study completedNCT02085395
What this trial is testing

Clinical Study Assessment of SR-T100 Topical Gel Against Actinic Keratosis

Who this might be right for
Actinic KeratosisBowen's Disease
G&E Herbal Biotechnology Co., LTD 27
Testing effectiveness (Phase 2)Study completedNCT01458587
What this trial is testing

Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK)

Who this might be right for
Keratosis, Actinic
DUSA Pharmaceuticals, Inc. 70
Large-scale testing (Phase 3)Study completedNCT00987246
What this trial is testing

Study on the Efficacy of LAS41005 in the Treatment of Actinic Keratosis

Who this might be right for
Actinic Keratosis
Almirall, S.A. 470
Not applicableStudy completedNCT07290959
What this trial is testing

Indoor Daylight Photodynamic Therapy is an Effective, First-line Treatment for AK, But Its Feasibility is Limited by the Time Required for the Illumination (2 Hours). Our Objective Was to Evaluate the Efficacy of Idl-PDT With an Illumination Time of 1 Hour Versus 2 Hours in the Treatment of Scalp AK

Who this might be right for
Actinic Keratosis (AK)
San Salvatore Hospital of L'Aquila 55
Post-approval studies (Phase 4)UnknownNCT01656226
What this trial is testing

Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic Keratosis

Who this might be right for
Actinic Keratosis
ISDIN 50
Testing effectiveness (Phase 2)Study completedNCT00991861
What this trial is testing

Efficacy and Safety Study of LAS41007 in the Treatment of Actinic Keratosis

Who this might be right for
Actinic Keratosis
Almirall, S.A. 100
Very early researchLooking for participantsNCT07286318
What this trial is testing

Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

Who this might be right for
Skin CancerCutaneous Squamous Cell Carcinoma (CSCC)Actinic Keratosis (AK)+1 more
Marissa Lobl 20
Load More Results